These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
332 related items for PubMed ID: 19129740
1. Effects of acetylsalicylic acid on increase of fibrin network porosity and the consequent upregulation of fibrinolysis. He S, Bark N, Wang H, Svensson J, Blombäck M. J Cardiovasc Pharmacol; 2009 Jan; 53(1):24-9. PubMed ID: 19129740 [Abstract] [Full Text] [Related]
2. Marked increase of fibrin gel permeability with very low dose ASA treatment. Antovic A, Perneby C, Ekman GJ, Wallen HN, Hjemdahl P, Blombäck M, He S. Thromb Res; 2005 Jan; 116(6):509-17. PubMed ID: 16181986 [Abstract] [Full Text] [Related]
3. Effects of aspirin on clot structure and fibrinolysis using a novel in vitro cellular system. Ajjan RA, Standeven KF, Khanbhai M, Phoenix F, Gersh KC, Weisel JW, Kearney MT, Ariëns RA, Grant PJ. Arterioscler Thromb Vasc Biol; 2009 May; 29(5):712-7. PubMed ID: 19286636 [Abstract] [Full Text] [Related]
5. Effects of poloxamer 188 on the assembly, structure and dissolution of fibrin clots. Carr ME, Powers PL, Jones MR. Thromb Haemost; 1991 Nov 01; 66(5):565-8. PubMed ID: 1803621 [Abstract] [Full Text] [Related]
6. The thrombin activation pathway modulates the assembly, structure and lysis of human plasma clots in vitro. Torbet J. Thromb Haemost; 1995 May 01; 73(5):785-92. PubMed ID: 7482404 [Abstract] [Full Text] [Related]
7. Modified clotting properties of fibrinogen in the presence of acetylsalicylic acid in a purified system. He S, Blombäck M, Yoo G, Sinha R, Henschen-Edman AH. Ann N Y Acad Sci; 2001 May 01; 936():531-5. PubMed ID: 11460511 [Abstract] [Full Text] [Related]
8. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor. von dem Borne PA, Cox LM, Bouma BN. Blood Coagul Fibrinolysis; 2006 Jun 01; 17(4):251-7. PubMed ID: 16651866 [Abstract] [Full Text] [Related]
9. Abnormal fibrin clot architecture in nephrotic patients is related to hypofibrinolysis: influence of plasma biochemical modifications: a possible mechanism for the high thrombotic tendency? Colle JP, Mishal Z, Lesty C, Mirshahi M, Peyne J, Baumelou A, Bensman A, Soria J, Soria C. Thromb Haemost; 1999 Nov 01; 82(5):1482-9. PubMed ID: 10595642 [Abstract] [Full Text] [Related]
10. Fibrin gel network characteristics and coronary heart disease: relations to plasma fibrinogen concentration, acute phase protein, serum lipoproteins and coronary atherosclerosis. Fatah K, Hamsten A, Blombäck B, Blombäck M. Thromb Haemost; 1992 Aug 03; 68(2):130-5. PubMed ID: 1384157 [Abstract] [Full Text] [Related]
11. Assays of fibrin network properties altered by VKAs in atrial fibrillation - importance of using an appropriate coagulation trigger. Ząbczyk M, Blombäck M, Majewski J, Karkowski G, Wallen HN, Undas A, He S. Thromb Haemost; 2015 Apr 03; 113(4):851-61. PubMed ID: 25518887 [Abstract] [Full Text] [Related]
12. Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects. Undas A, Brozek J, Jankowski M, Siudak Z, Szczeklik A, Jakubowski H. Arterioscler Thromb Vasc Biol; 2006 Jun 03; 26(6):1397-404. PubMed ID: 16574890 [Abstract] [Full Text] [Related]